These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients. Sakamoto Y, Mashiko K, Matsumoto H, Hara Y, Kutsukata N, Yamamoto Y. ASAIO J; 2007; 53(3):324-8. PubMed ID: 17515723 [Abstract] [Full Text] [Related]
6. Vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in septic shock patients treated with direct hemoperfusion with a polymyxin B-immobilized fiber column. Ebihara I, Hirayama K, Kaneko S, Nagai M, Ogawa Y, Fujita S, Usui J, Mase K, Yamagata K, Kobayashi M. Ther Apher Dial; 2008 Aug; 12(4):285-91. PubMed ID: 18789115 [Abstract] [Full Text] [Related]
8. Early induction of PMX-DHP improves oxygenation in severe sepsis patients with acute lung injury. Suyama H, Kawasaki Y, Morikawa S, Kaneko K, Yamanoue T. Hiroshima J Med Sci; 2008 Dec; 57(3-4):79-84. PubMed ID: 19260559 [Abstract] [Full Text] [Related]
9. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock. Naka T, Shinozaki M, Akizawa T, Shima Y, Takaesu H, Nasu H. Ther Apher Dial; 2006 Feb; 10(1):7-11. PubMed ID: 16556130 [Abstract] [Full Text] [Related]
11. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock. Yamashita C, Hara Y, Kuriyama N, Nakamura T, Nishida O. Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218 [Abstract] [Full Text] [Related]
12. Relationship between treatment resistance to hemoperfusion using a polymyxin B-immobilized fiber column and oxidative stress. Sakamoto Y, Mashiko K, Obata T, Matsumoto H, Hara Y, Kutsukata N, Yamamoto Y. ASAIO J; 2008 Aug; 54(4):412-5. PubMed ID: 18645360 [Abstract] [Full Text] [Related]
14. Clinical effects of use polymyxin B fixed on fibers in liver transplant patients with severe sepsis or septic shock. Ruberto F, Pugliese F, D'Alio A, Martelli S, Bruno K, Marcellino V, Perrella S, Cappannoli A, Mazzarino V, Tosi A, Novelli G, Rossi M, Ginanni Corradini S, Ferretti G, Berloco PB, Pietropaoli P. Transplant Proc; 2007 Aug; 39(6):1953-5. PubMed ID: 17692664 [Abstract] [Full Text] [Related]
16. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy. Berto P, Ronco C, Cruz D, Melotti RM, Antonelli M. Blood Purif; 2011 Aug; 32(4):331-40. PubMed ID: 22086346 [Abstract] [Full Text] [Related]
17. Effect over time of endotoxin adsorption therapy in sepsis. Ueno T, Sugino M, Nemoto H, Shoji H, Kakita A, Watanabe M. Ther Apher Dial; 2005 Apr; 9(2):128-36. PubMed ID: 15828924 [Abstract] [Full Text] [Related]